Mechanistic Approaches to Predicting Oral Drug Absorption
暂无分享,去创建一个
[1] J. Dressman,et al. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.
[2] P J Sinko,et al. Development of predictive pharmacokinetic simulation models for drug discovery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[3] G. Amidon,et al. Absorption potential: estimating the fraction absorbed for orally administered compounds. , 1985, Journal of pharmaceutical sciences.
[4] K. Pang,et al. A new physiologically based, segregated-flow model to explain route-dependent intestinal metabolism. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[5] Ho-Chul Shin,et al. Why is it Challenging to Predict Intestinal Drug Absorption and Oral Bioavailability in Human Using Rat Model , 2006, Pharmaceutical Research.
[6] G L Amidon,et al. A compartmental absorption and transit model for estimating oral drug absorption. , 1999, International journal of pharmaceutics.
[7] L. Schanker. On the mechanism of absorption of drugs from the gastrointestinal tract. , 1960, Journal of medicinal and pharmaceutical chemistry.
[8] Yatindra Joshi,et al. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. , 2004, Journal of pharmaceutical sciences.
[9] D. Flanagan,et al. General solution for diffusion-controlled dissolution of spherical particles. 1. Theory. , 1999, Journal of pharmaceutical sciences.
[10] Thierry Lavé,et al. Predicting Pharmacokinetic Food Effects Using Biorelevant Solubility Media and Physiologically Based Modelling , 2006, Clinical pharmacokinetics.
[11] Gordon L. Amidon,et al. Estimating the Fraction Dose Absorbed from Suspensions of Poorly Soluble Compounds in Humans: A Mathematical Model , 1993, Pharmaceutical Research.
[12] P. Sinko,et al. Carrier‐mediated intestinal absorption of valacyclovir, the L‐valyl ester prodrug of acyclovir. 1. Interactions with peptides, organic anions and organic cations in rats , 1998, Biopharmaceutics & drug disposition.
[13] B. C. Goodacre,et al. A MATHEMATICAL MODEL OF DRUG ABSORPTION , 1981, Journal of clinical and hospital pharmacy.
[14] Michael B. Bolger,et al. Application of Gastrointestinal Simulation for Extensions for Biowaivers of Highly Permeable Compounds , 2008, The AAPS Journal.
[15] W. Schmitt,et al. A Physiologic Model for Simulating Gastrointestinal Flow and Drug Absorption in Rats , 2003, Pharmaceutical Research.
[16] K. Higaki,et al. Prediction of the Plasma Concentration Profiles of Orally Administered Drugs in Rats on the Basis of Gastrointestinal Transit Kinetics and Absorbability , 1997, The Journal of pharmacy and pharmacology.
[17] M. Jamei,et al. Prediction of the in vivo behaviour of modified release formulations of metoprolol from in vitro dissolution profiles using the ADAM model (Simcyp V8) , 2008 .
[18] B Agoram,et al. Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.
[19] A. Dokoumetzidis,et al. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models , 2007, Expert opinion on drug metabolism & toxicology.
[20] Matthew D. Troutman,et al. Novel Experimental Parameters to Quantify the Modulation of Absorptive and Secretory Transport of Compounds by P-Glycoprotein in Cell Culture Models of Intestinal Epithelium , 2003, Pharmaceutical Research.
[21] Mary F Paine,et al. THE HUMAN INTESTINAL CYTOCHROME P450 “PIE” , 2006, Drug Metabolism and Disposition.
[22] J. Dressman,et al. Mixing-tank model for predicting dissolution rate control or oral absorption. , 1986, Journal of pharmaceutical sciences.
[23] P. Neuvonen,et al. Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin. , 1998, British journal of clinical pharmacology.
[24] Gordon L Amidon,et al. A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals , 2002, Journal of clinical pharmacology.
[25] Yuichi Sugiyama,et al. Effects of Intestinal CYP3A4 and P-Glycoprotein on Oral Drug Absorption—Theoretical Approach , 1999, Pharmaceutical Research.
[26] Gordon L. Amidon,et al. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon , 1987, Journal of Pharmacokinetics and Biopharmaceutics.
[27] Walter Schmitt,et al. A physiological model for the estimation of the fraction dose absorbed in humans. , 2004, Journal of medicinal chemistry.
[28] Patrick J. Sinko,et al. Predicting Fraction Dose Absorbed in Humans Using a Macroscopic Mass Balance Approach , 1991, Pharmaceutical Research.
[29] G Mannens,et al. Strategies for absorption screening in drug discovery and development. , 2001, Current topics in medicinal chemistry.
[30] M. Jamei,et al. A Novel Physiologically-Based Mechanistic ModelPredicting Oral Drug Absorption: The Advanced Dissolution, Absorption, and Metabolism (ADAM) Model , 2007 .
[31] K. Higaki,et al. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[32] K. Pang,et al. Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[33] G L Amidon,et al. Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[34] R. Neubert,et al. Intestinal Transport of β-Lactam Antibiotics: Analysis of the Affinity at the H+/Peptide Symporter (PEPT1), the Uptake into Caco-2 Cell Monolayers and the Transepithelial Flux , 2004, Pharmaceutical Research.
[35] G. Grass,et al. Simulation models to predict oral drug absorption from in vitro data , 1997 .
[36] A. Urtti,et al. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[37] L. A. Fenu,et al. Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Tested Drugs , 2007, Drug Metabolism and Disposition.
[38] Thierry Lavé,et al. Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[39] Raimar Löbenberg,et al. Dynamic Dissolution Testing To Establish In Vitro/In Vivo Correlations for Montelukast Sodium, a Poorly Soluble Drug , 2008, Pharmaceutical Research.
[40] Raimar Löbenberg,et al. Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Dissolution Behavior of Glibenclamide , 2000, Pharmaceutical Research.
[41] Michael B. Bolger,et al. In Silico Modeling of Non-Linear Drug Absorption for the P-gp Substrate Talinolol and of Consequences for the Resulting Pharmacodynamic Effect , 2006, Pharmaceutical Research.
[42] P. Macheras,et al. Toward a quantitative approach for the prediction of the fraction of dose absorbed using the absorption potential concept. , 1989, Biopharmaceutics & drug disposition.
[43] Stefan Willmann,et al. Development and Validation of a Physiology-based Model for the Prediction of Oral Absorption in Monkeys , 2007, Pharmaceutical Research.
[44] K. Higaki,et al. Analysis and prediction of absorption behavior for theophylline orally administered as powders based on gastrointestinal-transit-absorption (Gita) model. , 2002, Drug metabolism and pharmacokinetics.
[45] J. Fox,et al. THEORETICAL MODEL STUDIES OF INTESTINAL DRUG ABSORPTION V. NON-STEADY-STATE FLUID FLOW AND ABSORPTION , 1980 .
[46] Gordon L. Amidon,et al. Comparison of Human Duodenum and Caco-2 Gene Expression Profiles for 12,000 Gene Sequences Tags and Correlation with Permeability of 26 Drugs , 2002, Pharmaceutical Research.
[47] Isadore Kanfer,et al. Physicochemical characterization of five glyburide powders: a BCS based approach to predict oral absorption. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[48] V. Ganapathy,et al. Differential Recognition of β-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2 (*) , 1995, The Journal of Biological Chemistry.
[49] G. Amidon,et al. Physicochemical model for dose-dependent drug absorption. , 1984, Journal of pharmaceutical sciences.
[50] Kazutaka Higaki,et al. Gastrointestinal transit and drug absorption. , 2000, Biological & pharmaceutical bulletin.
[51] G. Amidon,et al. Mass Balance Approaches for Estimating the Intestinal Absorption and Metabolism of Peptides and Analogues: Theoretical Development and Applications , 1993, Pharmaceutical Research.
[52] F. Tse,et al. Pharmacokinetics and pharmacodynamics of bromocriptine in the rat. , 1985, Biopharmaceutics & drug disposition.
[53] Martin Kuentz,et al. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[54] Lawrence X. Yu. An Integrated Model for Determining Causes of Poor Oral Drug Absorption , 1999, Pharmaceutical Research.
[55] Patrick J. Sinko,et al. Estimating Human Oral Fraction Dose Absorbed: A Correlation Using Rat Intestinal Membrane Permeability for Passive and Carrier-Mediated Compounds , 2004, Pharmaceutical Research.
[56] K. Higaki,et al. Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[57] K. Higaki,et al. Analysis and prediction of absorption behavior of colon-targeted prodrug in rats by GI-transit-absorption model. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[58] Walter Schmitt,et al. PK-Sim®: a physiologically based pharmacokinetic ‘whole-body’ model , 2003 .
[59] M. Paine,et al. P-Glycoprotein Increases from Proximal to Distal Regions of Human Small Intestine , 2003, Pharmaceutical Research.
[60] G. Amidon,et al. "5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter,". , 1999, Pharmaceutical research.
[61] H. Lennernäs,et al. Regional Jejunal Perfusion, a New in Vivo Approach to Study Oral Drug Absorption in Man , 1995, Pharmaceutical Research.
[62] G L Amidon,et al. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. , 1996, Advanced drug delivery reviews.
[63] Leslie Z Benet,et al. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. , 2008, Advanced drug delivery reviews.